Pharmacological characteristics and side effects of a new galenic formulation of propofol without soyabean oil

Anaesthesia

Volumn 58, Issue 11, 2003, Pages 1056-1062

  Paul, Mathias ^a   Dueck, M ^a   Kampe, S ^a   Fruendt, H ^a   Kasper, S M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anaesthetics, intravenous: propofol; Complications, thrombosis

Indexed keywords

AM 149; ANESTHETIC AGENT; PARACETAMOL; PROPOFOL; SOYBEAN OIL;

ADULT; ANESTHESIA INDUCTION; APNEA; AREA UNDER THE CURVE; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; EDEMA; ERYTHEMA; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MIGRAINE; MORBIDITY; NAUSEA AND VOMITING; NORMAL HUMAN; PAIN; PARALLEL DESIGN; PATIENT MONITORING; PHARMACODYNAMICS; PHARMACOLOGICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; THROMBOPHLEBITIS;

ADULT; ANESTHETICS, INTRAVENOUS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXCIPIENTS; HUMANS; MALE; PAIN; PROPOFOL; SOYBEAN OIL; THROMBOPHLEBITIS;

EID: 0242364210     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2003.03345.x     Document Type: Article

References (31)

1. Fulton B, Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50: 636-57.
2. Kay B, Rolly G. ICI 35868, a new intravenous induction agent. Acta Anaesthesiologica Belgica 1977; 28: 303-16.
3. Glen JB, Hunter SC. Pharmacology of an emulsion formulation of ICI 35868. British Journal of Anaesthesia 1984; 56: 617-26.
4. Gempeler F, Elston AC, Thompson SP, Park GR. Propofol and intralipid cause creaming of serum from critically ill patients. Anaesthesia 1994; 49: 17-20.
5. Crowther J, Hrazdil J, Jolly DT, Galbraith JC, Greacen M, Grace M. Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental. Anesthesia and Analgesia 1996; 82: 475-8.
6. Bennett SN, McNeil MM, Bland LA et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. New England Journal of Medicine 1995; 333: 147-54.
7. Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology 1994; 81: 1005-43.
8. Doenicke AW, Roizen MF, Rau J, Kellermann W, Babl J. Reducing pain during propofol injection: The role of the solvent. Anesthesia and Analgesia 1996; 82: 472-4.
9. Cox EH, Knibble CA, Koster VA et al. Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol. Pharmaceutical Research 1998; 15: 442-8.
10. Dutta S, Ebling WF. Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats. Journal of Pharmacy and Pharmacology 1998; 50: 37-42.
11. Johnston R, Noseworthy T, Anderson B, Konopad E, Grace M. Propofol versus thiopental for outpatient anesthesia. Anesthesiology 1987; 67: 431-3.
12. Sebel PS, Lowdon JD. Propofol: A new intravenous anesthetic. Anesthesiology 1989; 71: 260-77.
13. Plummer GF. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography 1987; 421: 171-6.
14. Cockshott ID, Briggs LP, Douglas EJ, White M. Pharmacokinetics of propofol in female patients. Studies using single bolus injections. British Journal of Anaesthesia 1987; 59: 1103-10.
15. Kaul S, Igwemezie LN, Stewart DJ et al. Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors. Journal of Clinical Oncology 1995; 13: 2835-41.
16. Dawson DJ. Comparing treatment groups on the basis of slopes, area under-the-curve and other summary measures. Drug Information Journal 1994; 28: 723-32.
17. Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia 1998; 53: 468-76.
18. Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69: 348-56.
19. Cockshott ID. Propofol ('Diprivan') pharmacokinetics and metabolism - An overview. Postgraduate Medical Journal 1985; 61 (Suppl. 3): 45-50.
20. Ducharme J, Varin F, Bevan DR, Donati F. Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters. Clinical Pharmacokinetics 1993; 24: 507-18.
21. Paul M, Fisher DM. Pharmacodynamic modeling of muscle relaxants. Effect of design issues on results. Anesthesiology 2002; 96: 711-17.
22. Kazama T, Ikeda K, Morita K et al. Investigation of effective anesthesia induction doses using a wide range of infusion rates with undiluted and diluted propofol. Anesthesiology 2000; 92: 1017-28.
23. Stephan H, Sonntag H, Schenk HD, Kettler D, Khambatta HJ. Effects of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism in patients with coronary artery disease. British Journal of Anaesthesia 1986; 58: 969-75.
24. Gold MI, Abraham EC, Herrington C. A controlled investigation of propofol, thiopentone and methohexitone. Canadian Journal of Anaesthesia 1987; 34: 478-83.
25. Nathanson MH, Gajraj NM, Russell JA. Prevention of pain on injection of propofol: A comparison of lidocaine with alfentanil. Anesthesia and Analgesia 1996; 82: 469-71.
26. Yokota S, Komatsu T, Komura Y et al. Pretreatment with topical 60% lidocaine tape reduces pain on injection of propofol. Anesthesia and Analgesia 1997; 85: 672-4.
27. Klement W, Arndt JO. Pain on injection of propofol: Effects of concentration and diluent. British Journal of Anaesthesia 1991; 67: 281-4.
28. Doenicke AW, Roizen MF, Rau J et al. Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesthesia and Analgesia 1997; 85: 1399-403.
29. Graham CW, Pagano RR, Conner JT. Pain and clinical thrombophlebitis following intravenous diazepam and lorazepam. Anaesthesia 1978; 33: 188-91.
30. Weber RS, Lopez-Berestein G. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope 1987; 97: 937-41.
31. Larsen B, Beerhalter U, Biedler A et al. Less pain on injection by a new formulation of propofol? A comparison with propofol LCT. Anaesthesist 2001; 50: 842-5.